Systemic inflammatory response syndrome in nosocomial bloodstream infections with Pseudomonas aeruginosa and Enterococcus species: Comparison of elderly and nonelderly patients

Journal of the American Geriatrics Society

Volumn 54, Issue 5, 2006, Pages 804-808

  Marra, Alexandre R ^a,b,c   Bar, Katharine ^b   Bearman, Gonzalo M L ^b   Wenzel, Richard P ^b   Edmond, Michael B ^b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c A D Williams Clinic   (United States)

Author keywords

Bloodstream infection; Elderly patients; Enterococcus spp.; Pseudomonas aeruginosa; SIRS

Indexed keywords

ANTIINFECTIVE AGENT; IMIPENEM; VANCOMYCIN;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; BLOOD CULTURE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; ENTEROCOCCUS; FEMALE; HEMATOLOGIC DISEASE; HOSPITAL BED CAPACITY; HOSPITAL INFECTION; HUMAN; KIDNEY FAILURE; LIVER FAILURE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PSEUDOMONAS AERUGINOSA; RESPIRATORY FAILURE; STATISTICAL MODEL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TERTIARY HEALTH CARE; UNIVARIATE ANALYSIS; VANCOMYCIN RESISTANT ENTEROCOCCUS; AGE; BACTEREMIA; COMPARATIVE STUDY; GRAM NEGATIVE INFECTION; INTENSIVE CARE; LENGTH OF STAY; MICROBIOLOGY; MIDDLE AGED;

AGE FACTORS; AGED; BACTEREMIA; ENTEROCOCCUS; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE; LENGTH OF STAY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PSEUDOMONAS INFECTIONS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 33745002730     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2006.00698.x     Document Type: Article

References (17)

1. Angus DC, Linde-Zwirble WT, Lidicker J et al. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29:1303-1310.
2. Angus DC, Kelley MA, Schmitz RJ et al. Committee on Manpower for Pulmonary and Critical Care Societies (COMPACCS). Caring for the critically ill patient. Current and projected workforce requirements for care of the critically ill and patients with pulmonary disease: Can we meet the requirements of an aging population? JAMA 2000;284:2762-2770.
3. Gogos CA, Lekkou A, Papageorgiou O et al. Clinical prognostic markers in patients with severe sepsis: A prospective analysis of 139 consecutive cases. J Infect 2003;47:300-306.
4. Girard TD, Opal SM, Ely EW. Insights into severe sepsis in older patients: From epidemiology to evidence-based management. Clin Infect Dis 2005;40:719-727.
5. Greenberg BM, Atmar RL, Stager CE et al. Bacteraemia in the elderly: Predictors of outcome in an urban teaching hospital. J Infect 2005;50:288-295.
6. Jensen AG, Wachmann CH, Espersen F et al. Treatment and outcome of Staphylococcus aureus bacteremia: A prospective study of 278 cases. Arch Intern Med 2002;162:25-32.
7. Ely EW, Angus DC, Williams MD et al. Drotrecogin alfa (activated) treatment of older patients with severe sepsis. Clin Infect Dis 2003;37:187-195.
8. Wisplinghoff H, Bischoff T, Tallent SM et al. Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004;39:309-317.
9. Ibrahim EH, Sherman G, Ward S et al. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000;118:9-11.
10. Kollef MH, Sherman G, Ward S et al. Inadequate antimicrobial treatment of infections: A risk factor for hospital mortality among critically ill patients. Chest 1999;115:462-474.
11. Knaus WA, Draper EA, Wagner DP et al. APACHE II. A severity of disease classification system. Crit Care Med 1985;13:818-829.
12. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-874.
13. Fagon JY, Chastre J, Novara A et al. Characterization of intensive care unit patients using a model based on the presence or absence of organ dysfunctions and/or infection. The ODIN model. Intensive Care Med 1993;19:137-144.
14. Garner JS, Jarvis WR, Emori TB et al. CDC definitions for nosocomial infections. Am J Infect Control 1988;6:128-140.
15. Hamel MB, Davis RB, Teno JM et al. Older age, aggressiveness of care, and survival for seriously ill, hospitalized adults. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Ann Intern Med 1999;131:721-728.
16. Micek ST, Lloyd AE, Ritchie DJ et al. Pseudomonas aeruginosa bloodstream infection: Importance of appropriate initial antimicrobial therapy treatment. Antimicrob Agents Chemother 2005;49:1306-1311.
17. Shapiro NI, Wolfe RE, Moore RB et al. Mortality in emergency department sepsis (MEDS) score: A prospectively derived and validated clinical prediction rule. Crit Care Med 2003;31:670-675.